Befekadu Asfaw

Dr. Befekadu Asfaw


Research Focus & Metrics

Academic Career Length

39Years (1988-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 July 2000 in Human Molecular Genetics
Verified
Journal Article
Open access
PDF file
SKStanislav Kmoch
Stanislav Kmoch
JBJirí Brynda
Jirí Brynda
BABefekadu Asfaw
Befekadu Asfaw
KBKarel Bezouška
Karel Bezouška
Petr NovakPetr Novak
Petr Novak
MEMilan Elleder
Milan Elleder
We describe a 5-year-old boy with a unique congenital cataract caused by deposition of numerous birefringent, pleiochroic and macroscopically prismatic crystals. Crystal analysis with subsequent automatic Edman degradation and matrix-associated laser desorption ionization time-of-flight mass spectrometry have identified the crystal-forming protein as γD-crystallin (CRYGD) lacking the N-terminal methionine. Sequencing of the CRYGD gene has shown a heterozygous C→A transversion in position 109 of the inferred cDNA (36R→S transversion of the processed, N-terminal methionine-lacking CRYGD). The lens protein crystals were X-ray diffracting, and our crystal structure solution at 2.25 Å suggests that mutant R36S CRYGD has an unaltered protein fold. In contrast, the observed crystal packing is possible only with the mutant protein molecules that lack the bulky Arg36 side chain. This is the first described case of human cataract caused by crystallization of a protein in the lens. It involves the third known mutation in the CRYGD gene but offers, for the first time, a causative explanation of the phenotype.

1 April 2001 in Human Molecular Genetics
Verified
Journal Article
Open access
PDF file
HHH. Hulková
H. Hulková
MCM. Cervenková
M. Cervenková
JLJ. Ledvinová
J. Ledvinová
MTM. Tochácková
M. Tochácková
MHM. Hrebícek
M. Hrebícek
MEM. Elleder
M. Elleder
A fatal infantile storage disorder with hepatosplenomegaly and severe neurological disease is described. Sphingolipids, including monohexosylceramides (mainly glucosylceramide), dihexosylceramides (mainly lactosylceramide), globotriaosyl ceramide, sulphatides, ceramides and globotetraosyl ceramide, were stored in the tissues. In general, cholesterol and sphingomyelin levels were unaltered. The storage process was generalized and affected a number of cell types, with histiocytes, which infiltrated a number of visceral organs and the brain, especially involved. The ultrastructure of the storage lysosomes was membranous with oligolamellar, mainly vesicular, profiles. Infrequently, there were Gaucher-like lysosomes in histiocytes. The neuropathology was severe and featured neuronal storage and loss with a massive depopulation of cortical neurons and pronounced fibrillary astrocytosis. There was a paucity of myelin and stainable axons in the white matter with signs of active demyelination. Immunohistochemical investigations indicated that saposins A, B, C and D were all deficient. The patient was homozygous for a 1 bp deletion (c.803delG) within the SAP-B domain of the prosaposin gene which leads to a frameshift and premature stop codon. In the heterozygous parents, mutant cDNA was detected by amplification refractory mutation analysis in the nuclear, but not the cytoplasmic, fraction of fibroblast RNA, indicating that the mutant mRNA was rapidly degraded. The storage process in the proband resembled that of a published case from an unrelated family. Saposins were also deficient in this case, leading to its reclassification as prosaposin deficiency, and her mother was found to be a carrier for the same c.803delG mutation. Both of the investigated families came from the same district of eastern Slovakia.

1 April 2005 in Journal of Inherited Metabolic Disease
Verified
Journal Article
Closed access
PDF file
HPH. Pavlů‐Pereira
H. Pavlů‐Pereira
BAB. Asfaw
B. Asfaw
HPH. Poupčtová
H. Poupčtová
JLJ. Ledvinová
J. Ledvinová
JSJ. Sikora
J. Sikora
MEM. Elleder
M. Elleder

24 March 2009 in American Journal of Medical Genetics Part A
Verified
Journal Article
Open access
PDF file
LKLadislav Kuchař
Ladislav Kuchař
JLJana Ledvinová
Jana Ledvinová
MHMartin Hřebíček
Martin Hřebíček
HMHelena Myšková
Helena Myšková
LDLenka Dvořáková
Lenka Dvořáková
KHKlaus Harzer
Klaus Harzer
Prosaposin deficiency (pSap‐d) and saposin B deficiency (SapB‐d) are both lipid storage disorders caused by mutations in the PSAP gene that codes for the 65–70 kDa prosaposin protein, which is the precursor for four sphingolipid activator proteins, saposins A–D. We report on two new patients with PSAP gene defects; one, with pSap‐d, who had a severe neurovisceral dystrophy and died as a neonate, and the other with SapB‐d, who presented with a metachromatic leukodystrophy‐like disorder but had normal arylsulfatase activity. Screening for urinary sphingolipids was crucial to the diagnosis of both patients, with electrospray ionization tandem mass spectrometry also providing quantification. The pSap‐d patient is the first case with this condition where urinary sphingolipids have been investigated. Multiple sphingolipids were elevated, with globotriaosylceramide showing the greatest increase. Both patients had novel mutations in the PSAP gene. The pSap‐d patient was homozygous for a splice‐acceptor site mutation two bases upstream of exon 10. This mutation led to a premature stop codon and yielded low levels of transcript. The SapB‐d patient was a compound heterozygote with a splice‐acceptor site variant exclusively affecting the SapB domain on one allele, and a 2 bp deletion leading to a null, that is, pSap‐d mutation, on the other allele. Phenotypically, pSap‐d is a relatively uniform disease of the neonate, whereas SapB‐d is heterogeneous with a spectrum similar to that in metachromatic leukodystrophy. The possible existence of genotypes and phenotypes intermediate between those of pSap‐d and the single saposin deficiencies is speculated.

1 May 2017 in Analytical Biochemistry
Verified
Journal Article
Closed access
LKLadislav Kuchař
Ladislav Kuchař
JSJ. Sikora
J. Sikora
MGM.E. Gulinello
M.E. Gulinello
HPH. Poupetova
H. Poupetova
Agnieszka ŁugowskaAgnieszka Ługowska
Agnieszka Ługowska
JLJ. Ledvinova
J. Ledvinova

9 June 2005 in Neuropediatrics
Verified
Journal Article
Closed access
MEM. Elleder
M. Elleder
MJM. Jeřábková
M. Jeřábková
ABA. Befekadu
A. Befekadu
MHM. Hřebíček
M. Hřebíček
LBL. Berná
L. Berná
KHK. Harzer
K. Harzer
An infant presented with multifocal myoclonus and cyanotic hypoxemia immediately after birth, and severe feeding problems, a protein-losing enteropathy, massive ascites and grand-mal epilepsy marked his rapid downhill course, with death at 17 weeks. At 2 weeks, brain MRI revealed grey matter heterotopias in the parieto-occipital regions suggestive of a cortical morphogenetic disorder. In cultured skin fibroblasts, lipid storage and reduced activities of ceramidase, galactosylceramide β-galactosidase and glucosylceramide β-glucosidase were evident. Autopsy disclosed generalised lysosomal lipid storage with macrophages and adrenal cortex prominently affected. The pattern of stored lipids in cultured fibroblasts and in dewaxed spleen tissue blocks was compatible with a diagnosis of prosaposin (pSap) deficiency (pSap-d). Neuropathologically, there was a pronounced generalised neurolysosomal storage combined with a severe depletion of cortical neurons and extreme paucity of myelin and oligodendroglia. This pathology, in particular the massive neuronal loss, differed from that in other neurolipidoses and could be explained by the reduced hydrolysis of multiple sphingolipids and the loss of pSap's neurotrophic function. The absence of immunostainable saposins on tissue sections and the presence of a homozygous c.1 A > T mutation in the prosaposin gene confirmed the diagnosis. PSap-d may be an underdiagnosed condition in infants with severe neurological and dystrophic signs starting immediately after birth.